Basics
Description
Major depression:
- Depressed mood and associated signs and symptoms lasting more than 2 wk
- Significant morbidity and mortality, including risk of suicide
- Often coexists with other medical illness
Etiology
- Biologic illness associated with derangements in several neurotransmitter systems including serotonin, norepinephrine, and dopamine
- Contributing factors:
- Genetic predisposition
- Medical illness
- Medication effects
- Psychosocial stress: Depression may follow adverse life event, trauma, loss of important relationship, or life role
- Higher prevalence in women. (Woman make more suicide attempts; men are more likely to complete suicide successfully)
Diagnosis
Signs and Symptoms
- 5 or more symptoms for at least 2 wk. (One of the symptoms must be depressed mood or loss of interest or pleasure):
- Depressed mood
- Diminished interest or pleasure
- Change in appetite, weight loss/gain
- Sleep disturbance
- Fatigue or loss of energy
- Diminished concentration
- Feeling of worthlessness or guilt
- Recurrent thoughts of death or suicide
- Psychomotor agitation or retardation
- Subtypes: Psychotic features, melancholic, catatonic, atypical, postpartum, seasonal
- May be anxious/agitated or withdrawn
- Associated somatic complaints:
- Weakness, malaise
- Weight loss
- Headache, back pain
History
- Time course, acuity, stressors
- Review depressive symptoms (see above)
- Past medical history
- Past psychiatric history
- Medications (prescribed and over-the-counter)
- Substance use
- Family history
- Social and occupational history; losses, transitions, trauma, and other major life events
- Safety assessment:
- Suicide risk
- Risk of violence to others
- Assess ability to care for self, nutrition
- Collateral from family or outpatient providers
- Cultural and language differences may complicate evaluation; use interpreter when appropriate
Physical Exam
- Vital signs
- Neurologic exam:
- Motor exam: Station, gait, strength, tone, abnormal movements
- Cognitive exam: Orientation, attention, memory, language, executive function
- Mental status exam: Affect and mood, thought form and content
- Depression may be difficult to diagnose in children and adolescents. Indicators of major depression in children may include:
- Changes in school, home, and social functioning
- Changes in sleep
- Social withdrawal
- Somatic complaints
- Consult with a child psychiatrist
Rule-out bipolar disorder: May require different treatment (mood stabilizers, antipsychotics), also antidepressants may precipitate mania in bipolar patients
Essential Workup
- Identify signs and symptoms of major depression (see "Signs and Symptoms"¯)
- Use history and physical exam to guide further workup
- Rule-out associated or coexisting psychiatric and medical conditions, substance use
- Safety assessment
Diagnosis Tests & Interpretation
Lab
- 1st line:
- CBC; chemistries including electrolytes, BUN/creatinine, glucose, calcium, liver function tests
- Urinalysis
- Serum and urine toxicology screen
- Thyroid function tests
- B12 and folate
- 2nd line, guided by history and initial findings:
- HIV testing
- RPR
- ESR/CRP/ANA
Imaging
- Brain imaging: Recommended for atypical presentation or if focal neurologic findings
- MRI brain preferred over CT for detecting tumors, cerebrovascular accident, white matter changes
Differential Diagnosis
- Psychiatric illnesses:
- Dysthymic disorder
- Adjustment disorder
- Bipolar disorder
- Anxiety disorders, including acute stress reactions, PTSD
- Schizophrenia, schizoaffective disorder
- Personality disorder
- Eating disorder
- Substance-induced mood disorder
- Medical conditions that may cause or mimic depression:
- Drug induced:
- Antihypertensives
- Oral contraceptives
- Steroids
- Sedative-hypnotics
- Opioids
- Psychostimulants (in withdrawal phase)
- β-Blockers
- Metoclopramide
- Endocrine disorders:
- Hypothyroidism
- Adrenal insufficiency
- Diabetes mellitus
- Postpartum, perimenopausal, and premenstrual syndromes
- Tumors:
- Neurologic disorders:
- Dementia (early phase or frontal type)
- Epilepsy
- Parkinson disease
- Multiple sclerosis
- Huntington disease
- Stroke
- Head trauma; subdural hematoma
- Normal pressure hydrocephalus
- Infections:
- Hepatitis
- HIV
- Mononucleosis
- Nutritional disorders:
- Folate deficiency
- Pellagra
- Vitamin B12 deficiency
- Electrolyte disturbances
- End-stage renal, hepatic, pulmonary, and cardiovascular diseases
- Obstructive sleep apnea
- Chronic pain syndromes
Treatment
Pre-Hospital
- Ensure safety of patient and providers
- Understand local laws for involuntary commitment to hospital
Initial Stabilization/Therapy
- Safety: Assess risk of suicide, violence
- General medical evaluation
- Management:
- 1-to-1 observation and suicide precautions when appropriate
- Work up potential medical causes
Ed Treatment/Procedures
- Psychological management:
- Listen empathically to understand context and relevant stressors
- Reassurance and education (e.g., depression is a treatable condition)
- Initiate medications:
- Antidepressant medication may be initiated for some patients with clear diagnosis and established follow-up
- Usually takes weeks for antidepressant medications to resolve major depression
- Low-dose benzodiazepines or neuroleptics may be used for associated agitation, insomnia, or psychosis
- Choice of drug determined by:
- Indications, efficacy
- Side-effect profile and risks
- Convenience, cost, availability
- Selective serotonin reuptake inhibitors (SSRIs: fluoxetine, paroxetine, sertraline, citalopram, escitalopram):
- Well tolerated
- Side effects may include:
- Mild nausea
- Headache
- Anxiety, restlessness, insomnia
- Somnolence
- Sexual dysfunction
- Weight gain
- Minimal overdose risk
- Serotonin norepinephrine reuptake inhibitors (SNRIs: venlafaxine, duloxetine):
- Well tolerated
- May be helpful for some pain syndromes
- Side effects similar to SSRIs
- Dopaminenorepinephrine reuptake inhibitor (bupropion):
- Agitation, insomnia
- Tremor
- Decreased seizure threshold
- Well-tolerated; no sexual side effects
- Norepinephrine serotonin modulator (mirtazapine):
- Weight gain
- Sedation
- Orthostasis
- Constipation
- Tricyclic antidepressants (amitriptyline, imipramine, nortriptyline, clomipramine):
- Anticholinergic effects
- Weight gain
- Postural hypotension
- Sedation
- Decreased seizure threshold
- Cardiac risk; overdose can be fatal
- Nortriptyline is best tolerated
- Monoamine oxidase inhibitors (phenelzine, tranylcypromine, selegiline transdermal):
- Dietary and other medication restrictions to avoid hypertensive crisis
- Dangerous in overdose
Medication
Medication dosage ranges are for adults.
Dose may be titrated over weeks as indicated.
- Amitriptyline: Initial 25-50 mg/d PO
- Bupropion: 75-400 mg/d PO
- Citalopram: 20-40 mg/d PO
- Desvenlafaxine: 50 mg/d PO
- Duloxetine: 30-120 mg/d PO
- Escitalopram: 10-20 mg/d PO
- Fluoxetine: 20-60 mg/d PO
- Imipramine: Initial 25-50 mg/d PO
- Mirtazapine: 15-45 mg/d PO
- Nortriptyline: Initial 25 mg/d PO
- Paroxetine: 20-40 mg/d PO
- Phenelzine: 15-90 mg/d PO
- Sertraline: 50-200 mg/d PO
- Tranylcypromine: 10-60 mg/d PO
- Venlafaxine: 75-300 mg/d PO
First Line
SSRIs, SNRIs, bupropion, mirtazapine
Second Line
- Tricyclics and monoamine oxidase inhibitors
- Use with caution in geriatric or medically ill
- Consider ECT for severe or treatment-resistant depression, psychotic depression, or catatonia
- Older patients may require lower dose; pay careful attention to potential drug interactions
- Caution with orthostatic hypotension and cholinergic blockade
FDA "Black box"¯ warning: Antidepressants may increase risk of suicidal thinking and behavior in some children, adolescents, or young adults with depression
In pregnant or breast-feeding women pay special attention to risks and benefits of medication treatments-consider consultation with a specialist in perinatal psychiatry
Follow-Up
Disposition
Admission Criteria
- Patient is suicidal or at high risk for suicide. See "Suicide, Risk Evaluation"¯
- Minimal or unreliable social supports
- Symptoms so severe that continual observation or nursing supportive care is required
- Psychotic features
- Civil commitment for psychiatric hospitalization is necessary if the patient is refusing treatment and is at risk to harm self or others
Discharge Criteria
- Low suicide risk
- Adequate social support
- Close follow-up available
Issues for Referral
- Outpatient mental health appointments and/or partial (day) hospital for patients not admitted
- Insurance carrier may determine inpatient disposition and options for other levels of care
- Case management or social services in ED may be helpful for disposition issues
- Communicate and coordinate care with other providers including primary care
Followup Recommendations
Follow-up depends on severity of illness and risk:
- If not admitted, patients with significant symptoms should follow up in 1-2 wk
- When medication is initiated, patient should be seen in follow-up in 1-2 wk
- More stable patients or those with minor symptoms may be seen with less urgency
Pearls and Pitfalls
- Patients with depression experience significant morbidity and may present a risk of self-harm
- Consider other conditions that mimic depression; also coexisting psychiatric and medical conditions, substance use
- Know hospitalization and involuntary commitment criteria in your area
Additional Reading
- American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, third edition. Am J Psychiatry. 2010;167(suppl 10):1-152.
- Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358:55-68.
- Cassem NH. Mood disordered patients. In: Stern TA, Fricchione GL, Cassem NH, eds. MGH Handbook of General Hospital Psychiatry. 6th ed. St. Louis, MO: Mosby; 2010.
- Stewart DE. Clinical practice. Depression during pregnancy. N Engl J Med. 2011;365:1605-1611.
See Also (Topic, Algorithm, Electronic Media Element)
- Bipolar Disorder
- Psychosis, Medical vs. Psychiatric
- Psychiatric Commitment
- Suicide, Risk Evaluation
Codes
ICD9
- 296.20 Major depressive affective disorder, single episode, unspecified
- 296.24 Major depressive affective disorder, single episode, severe, specified as with psychotic behavior
- 296.30 Major depressive disorder, recurrent episode, unspecified degree
- 648.40 Mental disorders of mother, unspecified as to episode of care or not applicable
- V62.84 Suicidal ideation
ICD10
- F32.3 Major depressv disord, single epsd, severe w psych features
- F32.9 Major depressive disorder, single episode, unspecified
- F33.9 Major depressive disorder, recurrent, unspecified
- F53 Puerperal psychosis
- R45.851 Suicidal ideations
SNOMED
- 35489007 Depressive disorder (disorder)
- 370143000 major depressive disorder (disorder)
- 73867007 Severe major depression with psychotic features (disorder)
- 58703003 postpartum depression (disorder)
- 267073005 Suicidal (finding)
- 320751009 Major depression, melancholic type (disorder)